We are live on ! Find out more
EWA

Evolution Wealth Advisors Portfolio holdings

AUM $981M
1-Year Est. Return 21.2%
This Fund
S&P 500
This Quarter Est. Return
-2.38%
1 Year Est. Return
+21.2%
3 Year Est. Return
+66.36%
5 Year Est. Return
+44.78%
10 Year Est. Return
AUM
$467M
AUM Growth
-$25.5M
Cap. Flow
-$10.1M
Cap. Flow %
-2.16%
Top 10 Hldgs %
56.62%
Holding
696
New
70
Increased
144
Reduced
141
Closed
33

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 4.08%
2 Technology 3.44%
3 Communication Services 1.92%
4 Financials 1.84%
5 Industrials 1.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRSK icon
576
Verisk Analytics
VRSK
$25.2B
$4K ﹤0.01%
18
WAB icon
577
Wabtec
WAB
$49.2B
$4K ﹤0.01%
51
WELL icon
578
Welltower
WELL
$173B
$4K ﹤0.01%
50
WRB icon
579
W.R. Berkley
WRB
$26.9B
$4K ﹤0.01%
117
WY icon
580
Weyerhaeuser
WY
$17.2B
$4K ﹤0.01%
108
XEL icon
581
Xcel Energy
XEL
$50.1B
$4K ﹤0.01%
68
ZBRA icon
582
Zebra Technologies
ZBRA
$12.5B
$4K ﹤0.01%
8
SILK
583
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$4K ﹤0.01%
73
-112
-61% -$5.86K
MRTX
584
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$4K ﹤0.01%
24
-46
-66% -$7.4K
GBT
585
DELISTED
Global Blood Therapeutics, Inc.
GBT
$4K ﹤0.01%
145
-221
-60% -$6.5K
PSTH
586
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
$4K ﹤0.01%
+200
New +$4.05K
CERN
587
DELISTED
Cerner Corp
CERN
$4K ﹤0.01%
57
ACAD icon
588
Acadia Pharmaceuticals
ACAD
$4.27B
$3K ﹤0.01%
162
-200
-55% -$3.85K
ALGS icon
589
Aligos Therapeutics
ALGS
$31.9M
$3K ﹤0.01%
8
-5
-38% -$1.98K
ARE icon
590
Alexandria Real Estate Equities
ARE
$8.65B
$3K ﹤0.01%
15
BBIO icon
591
BridgeBio Pharma
BBIO
$16.2B
$3K ﹤0.01%
68
-135
-67% -$7.24K
BCAB icon
592
BioAtla
BCAB
$5.63M
$3K ﹤0.01%
2
-2
-50% -$3.9K
BF.B icon
593
Brown-Forman Class B
BF.B
$12.1B
$3K ﹤0.01%
38
BR icon
594
Broadridge
BR
$16.7B
$3K ﹤0.01%
20
CE icon
595
Celanese
CE
$5.3B
$3K ﹤0.01%
20
CHD icon
596
Church & Dwight Co
CHD
$23B
$3K ﹤0.01%
33
CNTA
597
DELISTED
Centessa Pharmaceuticals
CNTA
$3K ﹤0.01%
+160
New +$3.31K
CRDF icon
598
Cardiff Oncology
CRDF
$66.9M
$3K ﹤0.01%
429
-381
-47% -$2.39K
CTVA icon
599
Corteva
CTVA
$59.2B
$3K ﹤0.01%
63
DLTR icon
600
Dollar Tree
DLTR
$23.5B
$3K ﹤0.01%
29

Similar funds

Evolution Wealth Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Evolution Wealth Advisors held 696 positions worth $467M, down 5.2% from $492M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Evolution Wealth Advisors's Q3 2021 filing shows 70 new, 144 increased, 141 reduced and 33 closed positions. Its largest new stake was TMC The Metals Company: 377,000 shares worth $1.72M. The largest sale was Rodgers Silicon Valley Acquisition Corp. Unit, an estimated $7.13M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 4.1% of assets, down from 4.5% a quarter earlier, followed by Technology and Communication Services.

  • Evolution Wealth Advisors's largest Q3 2021 buy was TMC The Metals Company: 377,000 shares worth $1.72M.
  • Evolution Wealth Advisors added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q3 2021, an estimated $6.94M increase.
  • Evolution Wealth Advisors's biggest Q3 2021 reduction was Vanguard Small-Cap ETF, cutting an estimated $6.89M.
  • Evolution Wealth Advisors fully exited Rodgers Silicon Valley Acquisition Corp. Unit in Q3 2021, selling an estimated $7.13M.
  • Evolution Wealth Advisors's ten largest holdings make up 57% of its $467M portfolio in Q3 2021.
  • Evolution Wealth Advisors opened 70 new positions and closed 33 in Q3 2021.
  • Evolution Wealth Advisors's portfolio value fell 5.2% quarter-over-quarter to $467M.

Based on Evolution Wealth Advisors's 13F filing for Q3 2021, filed 9 Nov 2021.